TOKYO - Claims that treatments can "reverse aging" or "attack cancer cells" are being used to promote regenerative medicine at private clinics across Japan, but a series of patient deaths and legal violations is raising concerns about safety.
As privately paid treatments such as stem cell therapies expand, newer procedures involving exosomes, tiny structures released by cells that carry signals between cells and play a role in the body's natural repair processes, have also emerged beyond the reach of existing legislation, prompting the health ministry to consider tightening regulations.
Log in or create a Free Membership
Account
or
Create accountFree Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.